EVOlocumab in Stable Heart Failure With Reduced Ejection Fraction of Ischemic Etiology: EVO-HF Pilot
Clinical trial NCT03791593 · COMPLETED
Trial details
- NCT number
- NCT03791593
- Sponsor
- Fundació Institut Germans Trias i Pujol
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-03
- Primary completion
- 2021-06-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.